BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29129294)

  • 1. Eosinophilic Esophagitis: Pathophysiology and Definition.
    Clayton F; Peterson K
    Gastrointest Endosc Clin N Am; 2018 Jan; 28(1):1-14. PubMed ID: 29129294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
    Jiao D; Ishimura N; Maruyama R; Ishikawa N; Nagase M; Oshima N; Aimi M; Okimoto E; Mikami H; Izumi D; Okada M; Ishihara S; Kinoshita Y
    J Gastroenterol; 2017 Feb; 52(2):203-210. PubMed ID: 27108416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
    Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the pathological understanding of eosinophilic esophagitis.
    Cianferoni A; Spergel JM; Muir A
    Expert Rev Gastroenterol Hepatol; 2015; 9(12):1501-10. PubMed ID: 26470602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression.
    Molina-Infante J; Rivas MD; Hernandez-Alonso M; Vinagre-Rodríguez G; Mateos-Rodríguez JM; Dueñas-Sadornil C; Perez-Gallardo B; Ferrando-Lamana L; Fernandez-Gonzalez N; Bañares R; Zamorano J
    Aliment Pharmacol Ther; 2014 Oct; 40(8):955-65. PubMed ID: 25112708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophilia.
    Park JY; Zhang X; Nguyen N; Souza RF; Spechler SJ; Cheng E
    PLoS One; 2014; 9(7):e101391. PubMed ID: 24988451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitis.
    Collison AM; Sokulsky LA; Sherrill JD; Nightingale S; Hatchwell L; Talley NJ; Walker MM; Rothenberg ME; Mattes J
    J Allergy Clin Immunol; 2015 Oct; 136(4):971-82. PubMed ID: 25981737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.
    Arias Á; Lucendo AJ
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):99-117. PubMed ID: 30791784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE).
    Chandramouleeswaran PM; Shen D; Lee AJ; Benitez A; Dods K; Gambanga F; Wilkins BJ; Merves J; Noah Y; Toltzis S; Yearley JH; Spergel JM; Nakagawa H; Malefyt Rd; Muir AB; Wang ML
    PLoS One; 2016; 11(3):e0150968. PubMed ID: 26992000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of Eosinophilic Esophagitis.
    O'Shea KM; Aceves SS; Dellon ES; Gupta SK; Spergel JM; Furuta GT; Rothenberg ME
    Gastroenterology; 2018 Jan; 154(2):333-345. PubMed ID: 28757265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-stromal crosstalk and fibrosis in eosinophilic esophagitis.
    Muir AB; Wang JX; Nakagawa H
    J Gastroenterol; 2019 Jan; 54(1):10-18. PubMed ID: 30101408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular immunological mechanisms in eosinophilic esophagitis: an updated overview of their clinical implications.
    Lucendo AJ
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):669-85. PubMed ID: 24742298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation.
    Simon D; Radonjic-Hösli S; Straumann A; Yousefi S; Simon HU
    Allergy; 2015 Apr; 70(4):443-52. PubMed ID: 25620273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of eosinophilic esophagitis.
    Blanchard C
    Curr Opin Gastroenterol; 2015 Jul; 31(4):321-7. PubMed ID: 26039724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
    McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
    Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.
    Doyle AD; Masuda MY; Kita H; Wright BL
    Front Immunol; 2020; 11():603295. PubMed ID: 33335531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE.
    Cheng E; Zhang X; Wilson KS; Wang DH; Park JY; Huo X; Yu C; Zhang Q; Spechler SJ; Souza RF
    PLoS One; 2016; 11(6):e0157376. PubMed ID: 27310888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic esophagitis: an immune-mediated esophageal disease.
    Weinbrand-Goichberg J; Segal I; Ovadia A; Levine A; Dalal I
    Immunol Res; 2013 Jul; 56(2-3):249-60. PubMed ID: 23579771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding fibrosis in eosinophilic esophagitis: Are we there yet?
    Armbruster-Lee J; Cavender CP; Lieberman JA; Samarasinghe AE
    J Leukoc Biol; 2018 Jul; 104(1):31-40. PubMed ID: 29377264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.